Literature DB >> 20089878

The psychometric validity of the NEI VFQ-25 for use in a low-vision population.

Manjula Marella1, Konrad Pesudovs, Jill E Keeffe, Patricia M O'Connor, Gwyneth Rees, Ecosse L Lamoureux.   

Abstract

PURPOSE: To determine the psychometric validity of the National Eye Institute-Visual Function Questionnaire (NEI VFQ-25) and its subscale structure for use in people with low vision.
METHODS: Two hundred thirty-two participants completed the NEI VFQ-25. Rasch analysis was used to test the psychometric performance of the questionnaire and each subscale. Factor models were hypothesized and tested with confirmatory factor analysis (CFA) and subsequently validated with Rasch analysis.
RESULTS: For the overall scale, two rating scales had to be dichotomized and three misfitting items removed to improve fit to the Rasch model. There was evidence of multidimensionality, indicating that the scale would benefit from scale splitting. For the NEI VFQ-25 subscale structure, six of the original 12 subscales could not fit the Rasch model because of item insufficiency (fewer than two items) and the remaining six displayed poor item fit characteristics indicating that the NEI VFQ-25 does not have a viable subscale structure. CFA supported a two-factor model with visual functioning (10 items) and socioemotional (9 items) scales. Most goodness-of-fit statistics were within the recommended range of values. The factor loadings of items on their respective scales were statistically significant (P < 0.001) and ranged between 0.59 and 0.84. The two scales individually fitted the Rasch model and were found to be unidimensional with adequate psychometric characteristics.
CONCLUSIONS: The native NEI VFQ-25 is a better performing instrument when split into visual functioning and socioemotional scales. These scales possess valid parameters for assessment of the impact of low vision in this population.

Entities:  

Mesh:

Year:  2010        PMID: 20089878     DOI: 10.1167/iovs.09-4494

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  57 in total

1.  [Psychometric properties of the FKS : Reliability, validity, Rasch analysis, and descriptive results of the German version of the Children's Visual Function Questionnaire].

Authors:  E Farin; M Metten; M Nagl; W A Lagrèze; C Pieh-Beisse
Journal:  Ophthalmologe       Date:  2011-07       Impact factor: 1.059

2.  Evaluation of the Adult Strabismus-20 (AS-20) questionnaire using Rasch analysis.

Authors:  David A Leske; Sarah R Hatt; Laura Liebermann; Jonathan M Holmes
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-04       Impact factor: 4.799

Review 3.  Patient-reported outcomes (PRO's) in glaucoma: a systematic review.

Authors:  S Vandenbroeck; S De Geest; T Zeyen; I Stalmans; F Dobbels
Journal:  Eye (Lond)       Date:  2011-03-18       Impact factor: 3.775

4.  Brow ptosis: are we measuring the right thing? The impact of surgery and the correlation of objective and subjective measures with postoperative improvement in quality-of-life.

Authors:  F Mellington; R Khooshabeh
Journal:  Eye (Lond)       Date:  2012-05-18       Impact factor: 3.775

5.  Development of an Arabic version of the National Eye Institute Visual Function Questionnaire as a tool to study eye diseases patients in Egypt.

Authors:  Nizar Saleh Abdelfattah; Mohamed Amgad; Ahmed A Salama; Marina E Israel; Ghada A Elhawary; Ahmed E Radwan; Mohamed M Elgayar; Tamer M El Nakhal; Islam T Elkhateb; Heba A Hashem; Doha K Embaby; Amira A Elabd; Reem K Elwy; Magdi S Yacoub; Hamdy Salem; Mohamed Abdel-Baqy; Ahmad Kassem
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

6.  The macular degeneration and aging study: Design and research protocol of a randomized trial for a psychosocial intervention with macular degeneration patients.

Authors:  Silvia Sörensen; Katherine White; Wingyun Mak; Katherine Zanibbi; Wan Tang; Amanda O'Hearn; Mark T Hegel
Journal:  Contemp Clin Trials       Date:  2015-03-24       Impact factor: 2.226

7.  What Is the Amount of Visual Field Loss Associated With Disability in Glaucoma?

Authors:  Alessandro A Jammal; Nara G Ogata; Fábio B Daga; Ricardo Y Abe; Vital P Costa; Felipe A Medeiros
Journal:  Am J Ophthalmol       Date:  2018-09-17       Impact factor: 5.258

8.  Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial.

Authors:  Jennifer Rose-Nussbaumer; N Venkatesh Prajna; K Tiruvengada Krishnan; Jeena Mascarenhas; Revathi Rajaraman; Muthiah Srinivasan; Anita Raghavan; Catherine E Oldenburg; Kieran S O'Brien; Kathryn J Ray; Stephen D McLeod; Travis C Porco; Thomas M Lietman; Nisha R Acharya; Jeremy D Keenan
Journal:  JAMA Ophthalmol       Date:  2015-06       Impact factor: 7.389

9.  Structural equation modeling: a framework for ocular and other medical sciences research.

Authors:  Sharon L Christ; David J Lee; Byron L Lam; D Diane Zheng
Journal:  Ophthalmic Epidemiol       Date:  2014-02       Impact factor: 1.648

10.  A low-vision rehabilitation program for patients with mild cognitive deficits.

Authors:  Heather E Whitson; Diane Whitaker; Guy Potter; Eleanor McConnell; Fay Tripp; Linda L Sanders; Kelly W Muir; Harvey J Cohen; Scott W Cousins
Journal:  JAMA Ophthalmol       Date:  2013-07       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.